Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience

Infections are the primary cause of morbidity and mortality in multiple myeloma (MM) patients (pts). The aim of our retrospective analysis was to evaluate incidence and course of COVID-19 infection in a cohort of 351 MM outpatients treated with novel drugs. COVID-19 disease was detected in 50/351 pt...

Descripción completa

Detalles Bibliográficos
Autores principales: Krejci, Marta, Pour, Ludek, Adam, Zdenek, Sandecka, Viera, Stork, Martin, Sevcikova, Sabina, Krejci, Martin, Knechtova, Zdenka, Kral, Zdenek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310901/
https://www.ncbi.nlm.nih.gov/pubmed/34309714
http://dx.doi.org/10.1007/s00277-021-04594-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310901/
https://www.ncbi.nlm.nih.gov/pubmed/34309714
http://dx.doi.org/10.1007/s00277-021-04594-w

Ejemplares similares